US Earnings Financial Results SEC Filings — August 24, 2026

Revenue grew 11.4% YoY to $202.3M, with equipment revenue up 10.0% and high-margin service revenue up 13.0%. Equipment gross margin surged 28.4% to 30.3%, while Non-GAAP Adjusted EBITDA rose 27.9% to $66.7M, signaling strong operational leverage and pricing power

Net income swung to +$12.75M in Q2 2026 from -$4.80M in Q2 2025, driven by a $19.05M gain on disposal of discontinued operations. Revenue grew 24.2% YoY to $9.79M, and net loss from continuing operations narrowed to -$1.17M from -$7.03M, indicating the core business is improving despite the accounting noise

Net income of $8.1M in Q2 2026 vs. -$0.3M a year ago, a massive turnaround driven by a $19.0M gain on asset sales. The company is monetizing assets to shore up the balance sheet, which could provide a cash buffer for restructuring

Adjusted gross margin declined 80 bps to 69.6% from 70.4%, and organic growth was 0%, signaling a mature business facing pricing and mix headwinds. The Diagnostics and Spatial Biology segment (held-for-sale) saw sales decline to $336.4M from $346.3M, a 2.9% drop

Net loss widened to -$2.0M in Q2 2026 from -$1.6M, while net sales declined 9.5% to $47.0M. Cash dropped to $0.3M from $0.9M, and the revolving credit facility balance increased to $6.0M from $2.0M, indicating a deteriorating liquidity position

As a pre-revenue SPAC with zero cash and a shareholder's deficit of $37,140 post-formation, the filing offers no operational signals. The only potential catalyst is a future business combination, but no target has been announced

Revenue grew 9.1% YoY to $14,400, and net loss improved to -$2,635 from -$4,024. However, the company remains in a negative equity position of ($87,277) and relies entirely on related-party loans for cash, making it a high-risk micro-cap with no path to profitability visible

Customer concentration is shifting; Walmart's share of sales declined to 29.7% from 31.4% YoY, while Dollar General's share rose to 16.9% from 14.2%. This shift toward a lower-margin retailer could be a headwind to gross margins

Net income of $12.75M is entirely driven by a $19.05M gain on disposal of discontinued operations. Operating cash flow remained negative at -$4.59M for H1 2026, meaning the core business is still burning cash. The $33.73M investment in equity securities and $7.83M equity method investee are new and unproven

Total revenue declined 54.7% in Q2 2026 and 42.6% in H1 2026 due to facility divestitures. Operating losses widened to -$2.1M (Q2) and -$3.4M (H1) from -$0.5M and -$0.9M a year ago, indicating the remaining operations are less profitable. Provision for credit losses increased 166.7% YoY

The 36-week net loss deepened to -$7.8M from -$6.6M, and total liabilities rose to $33.3M from $31.7M. With cash at just $0.3M and a $6.0M draw on the credit facility, the company faces a liquidity crunch if sales continue to decline

Flat organic growth (0%) and a declining adjusted gross margin (69.6% vs 70.4%) suggest the core business is stagnating. The Diagnostics and Spatial Biology segment, now held-for-sale, is shrinking, and the company is undergoing restructuring with $5.8M in related costs

Negative equity of ($87,277) and total liabilities of $100,695 exceed total assets. The company relies on related-party loans ($6,112 received in the quarter) to fund operations. Intangible assets are amortizing, and the net operating loss carryforward of $23,631 is fully offset by a valuation allowance, implying no near-term tax benefit

Zero cash and a shareholder's deficit of $37,140 post-formation. As a SPAC with no operations and no announced target, the company is a pure shell with a ticking clock to find a deal or liquidate

Goodwill decreased 50.1% to $2.60M from $5.22M, primarily due to the disposal of discontinued operations. This suggests the company is shedding assets, and the remaining goodwill may be at risk if the core business does not stabilize

Accounts receivable from Dollar General jumped to 32.4% of total receivables (up from 26.4% YoY), while the retailer's sales share is only 16.9%. This mismatch could signal collection issues or extended payment terms, increasing credit risk

Equipment gross margin surged 28.4% to 30.3%, and services gross margin remained high at 90.3%. With SG&A improving to 21.9% of sales (from 23.2%), the company is demonstrating operating leverage. The $16M litigation charge is a one-time event; normalized net income would have been significantly higher. Trading on operational metrics, this is a potential value play

The pending sale of the Diagnostics and Spatial Biology segment (held-for-sale) could unlock shareholder value. The segment's sales declined to $336.4M, but a divestiture could streamline the business and improve margins. The restructuring is reducing costs ($5.8M in COGS vs $20.1M last year), suggesting a leaner, more profitable core is emerging

Revenue grew 24.2% YoY, and the net loss from continuing operations narrowed to -$1.17M from -$7.03M. If the core business can sustain this trajectory and the new equity investments ($33.73M) generate returns, the stock could re-rate significantly from current levels

The $19.0M gain on asset sales provides a cash infusion that could be used to pay down debt or invest in the remaining facilities. If the company can stabilize the shrinking revenue base and return to operating profitability, the current valuation may not reflect the turnaround potential

Revenue grew 9.1% YoY, and the net loss narrowed. If the company can secure a larger financing round or achieve a breakthrough in its mobile app business, the micro-cap valuation could offer asymmetric upside. The improved cash position ($6,985 from $282) is a small positive

The shift in customer concentration toward Dollar General (16.9% of sales, up from 14.2%) could be a positive if it represents a new growth channel. The company's products are staples, and a recovery in consumer spending could drive a sales rebound. The stock may be oversold given the low expectations

Service revenue grew 13.0% YoY and carries a 90.3% gross margin. This recurring revenue stream provides a stable base and is a key differentiator from peers. As the installed base grows, service revenue should continue to compound, driving margin expansion

Amortization of intangibles in COGS declined to $37.8M from $44.0M, and restructuring costs fell to $5.8M from $20.1M. As these non-cash and one-time charges roll off, reported GAAP earnings should improve, potentially surprising the market

3 of 8 companies (ConnectM, Selectis Health, and to a lesser extent Napco with its litigation charge) reported net income that was significantly impacted by non-recurring items. This is a critical theme for investors: headline earnings are not reflecting underlying business health. ConnectM's $12.75M net income is entirely from a disposal gain, and Selectis Health's $8.1M net income is from asset sales. Investors must look at operating cash flow and continuing operations to gauge true performance.

Bridgford Foods (cash down to $0.3M, credit line drawn to $6.0M) and Natics Corp. (negative equity, reliant on related-party loans) are facing severe liquidity constraints. This contrasts with Napco, which is generating cash. The theme suggests that small-cap companies without strong cash flows are increasingly vulnerable to a tightening credit environment.

Bio-Techne (selling Diagnostics and Spatial Biology segment) and ConnectM (disposing of discontinued operations) are actively reshaping their portfolios. This trend indicates that management teams are focusing on core, higher-margin businesses. The market may reward these companies if the remaining assets show improved growth and margins.

Bio-Techne (0% organic growth, adjusted gross margin down 80 bps) and Bridgford Foods (sales down 9.5%, losses widening) illustrate a broader challenge: companies are struggling to grow revenue and are seeing margins compress. This is a defensive signal for the broader market, suggesting that pricing power is limited and cost pressures persist.

Samos Energy Acquisition Corp's filings show that SPAC formation is still occurring, but the company has zero cash and a shareholder deficit post-formation. This suggests that the SPAC market is still active but may be attracting lower-quality sponsors. Investors should be wary of SPACs with no announced targets and thin capital bases.

Napco Security Technologies (service revenue up 13.0%, 90.3% gross margin) stands out as the only company with a clear, high-margin recurring revenue stream. This theme highlights the premium the market places on predictable, subscription-like revenue, especially in a flat-growth environment. Companies that can build such streams are likely to outperform.

Pending sale of Diagnostics and Spatial Biology segment. The company has classified it as held-for-sale as of June 30, 2025. Watch for an announcement of a buyer and the sale price, which will determine the capital return potential and the shape of the remaining business.

Liquidity crisis watch. With cash at $0.3M and a $6.0M draw on the credit facility, the company needs to reverse its sales decline or secure additional financing. The next quarterly filing (10-Q for Q3) will be critical to see if the trend worsens.

Operating cash flow inflection. The company is burning -$4.59M in H1 2026. Watch for the next filing to see if the core business can achieve positive operating cash flow, which would validate the narrowing loss from continuing operations.

Post-divestiture stability. After recognizing a $19.0M gain on asset sales, watch for the next quarter's revenue and operating loss figures. If the remaining facilities can stabilize revenue and narrow operating losses, the stock could be a turnaround play.

One-time charge normalization. The $16M litigation settlement depressed net income. Watch for the next quarter to see if earnings rebound to reflect the strong operational performance (11.4% revenue growth, 27.9% Adjusted EBITDA growth).

Business combination announcement. As a SPAC with no operations, the only catalyst is a target announcement. The company completed its IPO on July 13, 2026. Watch for any 8-K filings or press releases regarding a potential merger.

Financing or business development. The company is reliant on related-party loans. Watch for any announcement of a larger financing round, a strategic partnership, or a material contract that could change the company's trajectory.

Customer concentration shift. Dollar General's share of receivables jumped to 32.4% from 26.4%. Watch for any news about payment terms or collection issues with Dollar General, which could signal a credit event.